Kolon Life Science signs ‘INVOSSA’ export agreement to Saudi Arabia and UAE
Kolon Life Science(CEO Woo-Seok Lee) signed an exclusive sales & export agreement with Mundipharma as a strategic partner to enter Saudi Arabia and the United Arab Emirates(UAE) with ‘INVOSSA®-K,’ the first knee osteoarthritis therapy.
The agreement is the first case of entering the Middle East ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
